Balance Sheet
Cash Flow Statement
AmortizationOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Other financing activities (2016 - 2025)

Historic Other financing activities for RedHill Biopharma (RDHL) over the last 15 years, with Q2 2025 value amounting to $350.3 million.

  • RedHill Biopharma's Other financing activities fell 666.87% to $350.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $350.3 million, marking a year-over-year decrease of 666.87%. This contributed to the annual value of $375.1 million for FY2024, which is 341.97% down from last year.
  • RedHill Biopharma's Other financing activities amounted to $350.3 million in Q2 2025, which was down 666.87% from $375.1 million recorded in Q4 2024.
  • Over the past 5 years, RedHill Biopharma's Other financing activities peaked at $388.4 million during Q4 2023, and registered a low of $350.3 million during Q2 2025.
  • Its 5-year average for Other financing activities is $372.7 million, with a median of $375.6 million in 2022.
  • Its Other financing activities has fluctuated over the past 5 years, first skyrocketed by 187028.5% in 2021, then tumbled by 666.87% in 2025.
  • Over the past 5 years, RedHill Biopharma's Other financing activities (Quarter) stood at $375.2 million in 2021, then rose by 1.97% to $382.6 million in 2022, then grew by 1.5% to $388.4 million in 2023, then fell by 3.42% to $375.1 million in 2024, then decreased by 6.61% to $350.3 million in 2025.
  • Its Other financing activities was $350.3 million in Q2 2025, compared to $375.1 million in Q4 2024 and $375.3 million in Q2 2024.